The a2 Milk Company Ltd (A2M)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 6.870 |
|---|---|
| 52-week range | 4.640 – 9.399 |
| Return, 1 month / 3 months | +2.5% / −0.7% |
| Return, 1 year / 3 years | −20.5% / +84.5% |
| Trend | Below its 200-day average |
| RSI (14) | 59 |
| Volatility (1 year) | 39.3% |
| Worst drawdown (1 year) | -47.4% |
| Average daily value traded | 14.15M AUD |
| Dividend yield | 6.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The a2 Milk Company is a dairy business based in New Zealand that produces and markets milk and dairy products made from cows that naturally produce only the A2 type of beta-casein protein. Its range includes fresh milk, infant formula and other dairy goods sold under the a2 Milk brand. Customers are mainly households and families, and the products are sold in Australia, New Zealand, China and the United States through supermarkets, pharmacies and online channels.
On this site The a2 Milk Company Ltd appears as a stock on the Australian Securities Exchange (Australia), code A2M, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The a2 Milk Company Ltd (A2M) trades on the Australian Securities Exchange in Australia. It last closed at AUD 6.870 on 19 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 547 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.5% and over the last three months it fell 0.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.7% | ||
| From 52-week high | -26.8% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.7% | ||
| 6-month return | -2.8% | ||
| 12-month return, skipping the last month | -22.5% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.4% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 14.15M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.4% | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.9% |
|---|---|
| 1 month | +2.5% |
| 3 months | −0.7% |
| 6 months | −2.8% |
| 1 year | −20.5% |
| 3 years | +84.5% |
| 5 years | +9.1% |
Signals
| 50-day / 200-day average | 6.681 / 7.207 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.184 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | NZD 0.0649 |
| 8 Jul 2026 | NZD 0.2936 |
| 19 Mar 2026 | NZD 0.0815 |
| 18 Sep 2025 | NZD 0.0868 |
| 20 Mar 2025 | NZD 0.0657 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.